Navigation Links
60 Million People Would Die Due To NCD In India

Diseases like diabetes, cancer and heart attack that are commonly referred to as non-communicable diseases could cause much strain to the Indian economy, // claiming approximately $237 of the health care cost by 2015, according to estimates by World Health Organization.

While India lost five million people in 2005 to NCD, the toll might reach 60 million due to health related problems by 2015, says Robert Beaglehole, director of NCD, WHO.

He was speaking at an international symposium on cardiovascular diseases, strokes and diabetes at All India Institute of Medical Sciences (AIIMS) here.

'While India is poised to receive an 11 percent downturn in infectious diseases in 2006, the country would witness a 35 percent growth in diabetic patients and 18 percent growth in cardiovascular patients,' Beaglehole said.

He said since these diseases were affecting the younger age group, the economic impact on the country would be enormous.

'As people in the working age group (30-59) would increasingly succumb to such diseases, India would lose around $237 billion,' he warned.

In 2005, India lost an estimated $9 billion in national income from premature deaths due to such illnesses.

Speaking about the new report, 'Preventing Chronic Diseases: A Vital Investment', which he unveiled Friday, Beaglehole said: 'In the Southeast Asian region alone 54 percent of all deaths are due to chronic diseases and as many as 89 million people will die of it in this region in the next 10 years.'

With such a pandemic threat lurking, Beaglehole said that WHO proposes a global goal - to reduce the projected trend of chronic disease death rates by two percent per year till 2015.

'This may prevent 36 million people from dying of these diseases in the next 10 years,' he said.

Edited IANS
'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Over Six Million HIV Infected People In South Africa- Finds A Survey
3. Tanzanian Government Sanctions $20 Million For AIDS Arug
4. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
5. Number Of Babies Born Prematurely Nears Historic Half Million Mark In US
6. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
7. An Estimated 150 Million Indians Suffer From Arthritis
8. Acute Shortage Of Neurosurgeons In India: One Surgeon For Every 1 Million!
9. India To Procure 1 Million Doses Of Tamiflu
10. Global Warming Could Cause 5 Million Illnesses: WHO
11. Australia earmarks $74 Million to Fight Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Million People Would Die Due NCD India

(Date:12/2/2008)...ed with radiation prior to surgery for advanced re...nce and better overall survival rates, according t...ed a treatment called neoadjuvant therapy, which c... of cancer, before surgery to remove the tumor. Ne...radiation. , Neoadjuvant therapy should not be ...
(Date:12/2/2008)...n the December 1, 2008, issue of Clinical Cancer ...or Cancer Research, show lapatinib benefits women ... HER2-negative breast cancer or those who express ...ion, a misclassification of metastatic breast canc... people from receiving optimal therapy. , Lapat...
(Date:12/2/2008)...FirstCall/ - NUCRYST Pharmaceuticals Corp., a deve...ght infection and inflammation, announced today th...jority shareholder, The Westaim Corporation ("West...shareholders to consider a return of capital of US...tes to a return of capital of approximately US$15 ...
(Date:12/2/2008)...Call/ -- Today Pascal Metrics Inc.,publicly annou...sk management,services for hospitals and healthca...etrics rapidly has become a worldwide leader for c...d other regulatory requirements, to reduce,costs,...e patients safer from,medical failure and errors....
Breaking Medicine News(10 mins):Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2
... heart becomes so enlarged that it is no longer ab...s 35 in every 100,000 people. Researchers in the U...ished in the journal Science that a defect in the ...ays a key role in regulating the flow of calcium t...
...f The Anatomical Record has put together a collect...ry repair in animals. Spinal cord injury affects m...th little hope of living a normal life. However, r...tem cells - primitive cells that can turn into spe...
...ases in our society with more than five million pe...one. According to a major study in the UK, in whic...st 900,000 asthma patients across the UK, asthma s...t being prescribed the most suitable inhalers. The...
...at can often be fatal. Methadone has been one of t... However, the major concern in treating heroin add...ddictive. This is one reason methadone therapy is ...tudy has now found that an alternative drug therap...
Other Medicine News:
(Date:11/26/2008)...e-USNewswire/ -- Children whose eyes are misaligne... risk of developing mental illness by early adulth... published this month in Pediatrics , the official... , The retrospective study examined the medi...igned eyes) and compared them with records of chil...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-FirstCa...) announced today that it has received full approv...) for its U.S. pivotal trial to study the effectiv...associated therapy in the prevention of Contrast-I...approved PLC,s request to expand their investigati...
(Date:11/25/2008)...-USNewswire/ -- Kleinert Kutz and University of L...hand transplant on Messina, New York resident, Jan...Hand Care Center on Monday, November 24. The inno...ed shortly after 9 p.m. in a record nine hours. ,...prnh/20081125/DC48555-a ) , (Photo: http://ww...
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 1Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 2Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 3Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 4Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 1Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 1WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 3
... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e Acuity LT Central Monitoring Station allows emer... Delivery Area when and where it's needed. Central...-site in response to emergency situations to incre...nvolved., ,Used in conjunction with Welch Allyn's...
...ble and easy-to-use 3800 and 3900/P pulse oximeter...gy, the proprietary clinical patient motion algori...proved performance:, ,The 3800 and 3900 pulse.../ mechanical stress testing such as rough handling...
... the power of clinical information. , ,S/5 Clinic...ical connectivity solutions that help you and your...ent care. You will have access to essential patien...re team and specialists, independent of time and l...
...monitoring for intermediate care., ,The S/5 FM is...da S/5 product line., ,The S/5 FM has a modular d...tient Side Module (PSM) includes a comprehensive p...ECG, NIBP, motion-tolerant SpO 2 , 2 temperatures ...
Medicine Products: